tetano
Editor, Senior Moderator
CNA New York, April 17 (by Ruan Yulin) WHO indicated on the 17th, WHO flu cooperation center is researching and developing one type in view of the candidate vaccine virus of Type A H7N9 flu virus, But whether produces the Type A H7N9 flu virus vaccine to depend on the public health domain actual need. WHO indicated that decides to produce the Type A H7N9 flu virus vaccine and research and development candidate vaccine virus completely is two matters. Researches and develops the work of candidate viral strain to launch, and will complete within several weeks, but produces the decision of this type of vaccine not to make. The decision of production vaccine bases on the consideration of public health, how before making the decision must observe the Type A H7N9 flu virus to evolve. By 17th, China had 82 patients to be diagnosed to infect the H7N9 bird flu, 17 dead. WHO indicated that confirmed is over 1000 people to have the intimate contact with the H7N9 bird flu virus infected person. Although this new virus whether may not be confirmed in the interpersonal dissemination, but is carrying on the close monitoring to these people. WHO indicated that Before the origin of infection determines, it is estimated that China will have the new infection, but did not suggest that carries on screening in view of the Type A H7N9 flu virus in the entry port, as well as to China, Especially receives the local implementation travel or the restraint of trade that measure to China the bird flu affects. (End)
http://news.xinhuanet.com/health/2013-04/18/c_124599108.htm
http://news.xinhuanet.com/health/2013-04/18/c_124599108.htm